Live
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
- Akshaya Tritiya 2024 Auspicious Hindu Festival on May 10th
- Celebrating World Veterinary Day 2024: Safeguarding Your Pet’s Vision with Expert Tips
- NSG joins CBI in searching residence of Sheikh Shahjahan’s relative
- Maharashtra: Peeved state unit Congress Working President quits 2024 LS polls campaign
- Archery World Cup: Deepika storms into individual semis; Compound Mixed Team in final
- Adopt zero-tolerance approach towards terrorism, India tells SCO member states
- Free haircut, 'mehendi' for women on offer as Maharashtra votes in Phase 2
Johnson & Johnson Covid vaccine likely in India by July
(Image Source: Reuters)
The Covid-19 vaccine developed by Johnson & Johnson will likely be available in India in small quantities by July this year, sources said.
New Delhi: The Covid-19 vaccine developed by Johnson & Johnson will likely be available in India in small quantities by July this year, sources said.
The Association of Healthcare Providers (India) is in the process of privately procuring the vaccine directly from the US-based manufacturer. Johnson & Johnson's vaccine could arrive in India as early as July, though it will be limited to a few thousand doses initially. The one-shot vaccine will be priced at $25 in India.
The viral vector vaccine does not need to be stored frozen and is suitable for a country like India, which lacks the healthcare infrastructure for storage of vaccines in sub-zero temperatures in tier-2 regions and beyond.
Johnson & Johnson has already initiated talks with the Union government to authenticate its manufacturing process and specifications in the country.
